Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10/STAT3/PD-L1 signaling pathways

被引:64
|
作者
Deng, Xin-Xin [1 ,2 ]
Jiao, Yan-Na [1 ]
Hao, Hui-Feng [1 ]
Xue, Dong [1 ]
Bai, Chang-Cai [2 ]
Han, Shu-Yan [1 ]
机构
[1] Peking Univ, Dept Integrat Chinese & Western Med, Key Lab Carcinogenesis & Translat Res, Minist Educ,Canc Hosp & Inst, Beijing 100142, Peoples R China
[2] Ningxia Med Univ, Ningxia Res Ctr Modern Hui Med Engn & Technol, Key Lab Hui Ethn Med Modernizat, Minist Educ,Pharm Coll, Yinchuan 750004, Ningxia, Peoples R China
基金
中国国家自然科学基金;
关键词
Triple-negative breast cancer; Taraxacum mongolicum; Tumor-associated macrophages; IL-10; STAT3; PD-L1; EXPRESSION; CHEMOTHERAPY;
D O I
10.1016/j.jep.2021.113978
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Triple-negative breast cancer (TNBC) is the most aggressive and the worst prognosis breast cancer with limited treatment options. Taraxacum mongolicum (also called dandelion) is a traditional Chinese medicine has been used to treat mastitis, breast abscess, and hyperplasia of mammary glands since ancient times. In modern pharmacological research, dandelion has been proven with anti-breast cancer activities. We previously reported that dandelion extract could induce apoptosis in TNBC cells. However, its antitumor effects and mechanisms in the tumor microenvironment have not yet been elucidated. Aim of the study: Tumor-associated macrophages (TAMs) play an important role in regulating the interaction between tumor cells and the immune system. The present study aimed to investigate the effects and mechanisms of dandelion extract on TNBC cells under the microenvironment of TAMs, as well as its influence on the polarization of M2 macrophages. Materials and methods: M2 macrophages were induced by phorbol-12-myristate 13-acetate (PMA) and interleukin 4 (IL-4), and verified by flow cytometry, quantitative RT-PCR (qRT-PCR), Western blotting, and ELISA. MDA-MB231 and MDA-MB-468 TNBC cells were co-cultured with the supernatant of M2 macrophage which providing the TAMs microenvironment. The antitumor activity of dandelion extract in TNBC cells was evaluated by MTT assay. The invasive and migratory capacity of TNBC cells was measured by transwell assays. The expression of protein and gene was assessed by Western blotting and qRT-PCR, respectively. Results: TAMs microenvironment promoted the proliferation, migration, and invasion of TNBC cells. However, dandelion extract inhibited the malignant property of MDA-MB-231 and MDA-MB-468 cells induced by TAMs. Both of TAMs and IL-10 caused STAT3 activation and PD-L1 higher expression, the immunosuppressive molecules in TNBC cells, and this effect can be attenuated by IL-10 neutralizing antibody. Dandelion extract exerted inhibition on STAT3 and PD-L1 in TNBC cells under TAMs microenvironment. Furthermore, in M2 macrophages, dandelion extract remarkably promoted the expression of M1-like marker TNF-alpha, IL-8, and iNOS, but reduced M2-like marker IL-10, CD206, Arginase-1, and TGF-beta. Conclusion: Dandelion extract inhibited the proliferation, migration and invasion of TNBC cells in TAMs microenvironment through suppressing IL-10/STAT3/PD-L1 immunosuppressive signaling pathway. Furthermore, dandelion extract promoted the polarization of macrophages from M2 to M1 phenotype. Thus, our results indicated that dandelion may serve as a promising therapeutic strategy for TNBC by modulating tumor immune microenvironment.
引用
收藏
页数:11
相关论文
共 36 条
  • [21] Tumor-Associated Macrophages Regulate Murine Breast Cancer Stem Cells Through a Novel Paracrine EGFR/Stat3/Sox-2 Signaling Pathway
    Yang, Jian
    Liao, Debbie
    Chen, Cong
    Liu, Yan
    Chuang, Tsung-Hsien
    Xiang, Rong
    Markowitz, Dorothy
    Reisfeld, Ralph A.
    Luo, Yunping
    STEM CELLS, 2013, 31 (02) : 248 - 258
  • [22] Targeting DCLK1 attenuates tumor stemness and evokes antitumor immunity in triple-negative breast cancer by inhibiting IL-6/STAT3 signaling
    Liu, Heshu
    Yan, Rui
    Xiao, Zeru
    Huang, Xuying
    Yao, Jiannan
    Liu, Jian
    An, Guangyu
    Ge, Yang
    BREAST CANCER RESEARCH, 2023, 25 (01)
  • [23] Targeting DCLK1 attenuates tumor stemness and evokes antitumor immunity in triple-negative breast cancer by inhibiting IL-6/STAT3 signaling
    Heshu Liu
    Rui Yan
    Zeru Xiao
    Xuying Huang
    Jiannan Yao
    Jian Liu
    Guangyu An
    Yang Ge
    Breast Cancer Research, 25
  • [24] Oral squamous cell carcinoma cell-derived GM-CSF regulates PD-L1 expression in tumor-associated macrophages through the JAK2/STAT3 signaling pathway
    Wang, Pingping
    Tao, Liqing
    Yu, Yudu
    Wang, Qiong
    Ye, Peihong
    Sun, Yi
    Zhou, Jingping
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (02): : 589 - 601
  • [25] Spatial and Quantitative Analysis of Tumor-Associated Macrophages: Intratumoral CD163-/PD-L1+TAMs as a Marker of Favorable Clinical Outcomes in Triple-Negative Breast Cancer
    Shinohara, Hajime
    Kobayashi, Maki
    Hayashi, Kumiko
    Nogawa, Daichi
    Asakawa, Ayaka
    Ohata, Yae
    Kubota, Kazuishi
    Takahashi, Hisashi
    Yamada, Miyuki
    Tokunaga, Masanori
    Kinugasa, Yusuke
    Oda, Goshi
    Nakagawa, Tsuyoshi
    Onishi, Iichiroh
    Kinowaki, Yuko
    Kurata, Morito
    Ohashi, Kenichi
    Kitagawa, Masanobu
    Yamamoto, Kouhei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [26] eNAMPT/Ac-STAT3/DIRAS2 Axis Promotes Development and Cancer Stemness in Triple-Negative Breast Cancer by Enhancing Cytokine Crosstalk Between Tumor-Associated Macrophages and Cancer Cells
    Zhang, Lifen
    Wang, Lu
    Xu, Ziyao
    Zhang, Xingmei
    Guan, Shaoyu
    Liu, Zhe
    Gu, Shanzhi
    Zhao, Lin
    Bai, Weichao
    Li, Tian
    Zhao, Xinhan
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2025, 21 (05): : 2027 - 2047
  • [27] Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways
    Ibrahim, Sherif Abdelaziz
    Gadalla, Ramy
    El-Ghonaimy, Eslam A.
    Samir, Omnia
    Mohamed, Hossam Taha
    Hassan, Hebatallah
    Greve, Burkhard
    El-Shinawi, Mohamed
    Mohamed, Mona Mostafa
    Goette, Martin
    MOLECULAR CANCER, 2017, 16
  • [28] Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways
    Sherif Abdelaziz Ibrahim
    Ramy Gadalla
    Eslam A. El-Ghonaimy
    Omnia Samir
    Hossam Taha Mohamed
    Hebatallah Hassan
    Burkhard Greve
    Mohamed El-Shinawi
    Mona Mostafa Mohamed
    Martin Götte
    Molecular Cancer, 16
  • [29] FEZF2 inhibits the growth of triple-negative breast cancer cells through EZH2/PD-L1 and enhances anti-tumor immunity in vivo
    Li, Wenyu
    Liu, Hu
    Li, Wenjuan
    Zhang, Qiujun
    Zhang, Qianyu
    Hu, Dandan
    MOLECULAR & CELLULAR TOXICOLOGY, 2024, 20 (03) : 553 - 562
  • [30] Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6/Jak/Stat3 in PD-L1-high lung cancer
    Jeong, Hyein
    Koh, Jaemoon
    Kim, Sehui
    Yim, Jeemin
    Song, Seung Geun
    Kim, Hanbyeol
    Li, Yingying
    Lee, Soo Hyun
    Chung, Yeon Kyu
    Kim, Hongsoon
    Lee, Chul-Hwan
    Kim, Hye Young
    Keam, Bhumsuk
    Lee, Se-Hoon
    Chung, Doo Hyun
    Jeon, Yoon Kyung
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (03)